Skip to main content
Clinical Trials/NCT02540603
NCT02540603CompletedNot Applicable

Evaluation of a Full Face Mask for the Treatment of Obstructive Sleep Apnea (OSA) in NZ

Fisher and Paykel Healthcare0 sites15 target enrollmentStarted: September 1, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
15
Primary Endpoint
Number of participants with average system leak >60L/min

Study Overview

Brief Summary

This investigation is designed to evaluate the performance (leak and comfort) as well as participant's overall acceptance of the investigative full face mask amongst OSA participants.

Detailed Description

A total number of up to 15 OSA participants who currently use full face masks will be recruited for the trial. Participants will be on the trial for three weeks, using the prototypes at home for two weeks. PAP baseline data on the participant's prescribed treatment pressure with their usual mask and will be collected for one week prior to mask fitting with the full face trial mask.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18+ years of age
  • Diagnosed with OSA by a practicing physician
  • Prescribed PAP therapy (Bi-Level or Continuous Positive Airway Pressure (CPAP) or Automatic Positive Airway Pressure (APAP))
  • Existing full face users

Exclusion Criteria

  • Inability to give informed consent
  • Patients who are in a coma or decreased level of consciousness
  • Anatomical or physiological conditions making PAP therapy inappropriate (e.g unconsolidated facial fracture)
  • Commercial Drivers who are investigated by New Zealand Transport Agency (NZTA)
  • Current diagnosis of CO2 retention
  • Pregnant or think they may be pregnant

Outcomes

Primary Outcomes

Number of participants with average system leak >60L/min

Time Frame: Two weeks in-home use

Average system leak will be recorded through downloading of the data from the PAP device in L/min.

Secondary Outcomes

  • Number of participants that found the mask comfortable.(Two weeks in-home use)
  • Insights into mask fitting and removal.(Two weeks use)

Investigators

Sponsor
Fisher and Paykel Healthcare
Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials

Evaluation of a Full Face Mask for the... | Clinical Trial